Cardiovascular Blind Spots and How Cleerly Is Changing the Game
In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...
AARP Bulletin highlights how heart disease remains the #1 killer in America in its article "America's War Against Heart Disease," and why it seems little progress has been made to slow its reach.
AARP mentions Cleerly's innovative, AI-enabled analysis in its review of up-and-coming tools that may help diagnose heart disease before a heart attack. James Min, MD, Cleerly CEO, offers his perspective on how Cleerly can aid physicians in better diagnosing heart disease and types of atherosclerosis. Read the full article HERE.
In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...
CNBC interviews Cleerly CEO, James Min, MD, on how Cleerly aims to improve personalized cardiac care and create a world without heart attacks. Read...
In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...
In Today’s Medical Developments, Cleerly founder and CEO Dr. James K. Min explains why the current approach to cardiovascular care is flawed — and...